List of Tables
Table 1. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Percutaneous Coronary Intervention (PCI) Treatment Instruments as of 2024)
Table 11. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Companies Headquarters
Table 13. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Application (2026-2031) & (US$ Million)
Table 21. Percutaneous Coronary Intervention (PCI) Treatment Instruments High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Growth Accelerators and Market Barriers
Table 25. North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Growth Accelerators and Market Barriers
Table 27. Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Percutaneous Coronary Intervention (PCI) Treatment Instruments Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Percutaneous Coronary Intervention (PCI) Treatment Instruments Investment Opportunities and Key Challenges
Table 31. Central and South America Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Percutaneous Coronary Intervention (PCI) Treatment Instruments Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Medtronic Corporation Information
Table 35. Medtronic Description and Major Businesses
Table 36. Medtronic Product Features and Attributes
Table 37. Medtronic Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Medtronic Revenue Proportion by Product in 2024
Table 39. Medtronic Revenue Proportion by Application in 2024
Table 40. Medtronic Revenue Proportion by Geographic Area in 2024
Table 41. Medtronic Percutaneous Coronary Intervention (PCI) Treatment Instruments SWOT Analysis
Table 42. Medtronic Recent Developments
Table 43. Terumo Corporation Corporation Information
Table 44. Terumo Corporation Description and Major Businesses
Table 45. Terumo Corporation Product Features and Attributes
Table 46. Terumo Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Terumo Corporation Revenue Proportion by Product in 2024
Table 48. Terumo Corporation Revenue Proportion by Application in 2024
Table 49. Terumo Corporation Revenue Proportion by Geographic Area in 2024
Table 50. Terumo Corporation Percutaneous Coronary Intervention (PCI) Treatment Instruments SWOT Analysis
Table 51. Terumo Corporation Recent Developments
Table 52. Boston Scientific Corporation Information
Table 53. Boston Scientific Description and Major Businesses
Table 54. Boston Scientific Product Features and Attributes
Table 55. Boston Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Boston Scientific Revenue Proportion by Product in 2024
Table 57. Boston Scientific Revenue Proportion by Application in 2024
Table 58. Boston Scientific Revenue Proportion by Geographic Area in 2024
Table 59. Boston Scientific Percutaneous Coronary Intervention (PCI) Treatment Instruments SWOT Analysis
Table 60. Boston Scientific Recent Developments
Table 61. Cordis Corporation Information
Table 62. Cordis Description and Major Businesses
Table 63. Cordis Product Features and Attributes
Table 64. Cordis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Cordis Revenue Proportion by Product in 2024
Table 66. Cordis Revenue Proportion by Application in 2024
Table 67. Cordis Revenue Proportion by Geographic Area in 2024
Table 68. Cordis Percutaneous Coronary Intervention (PCI) Treatment Instruments SWOT Analysis
Table 69. Cordis Recent Developments
Table 70. Abbott Corporation Information
Table 71. Abbott Description and Major Businesses
Table 72. Abbott Product Features and Attributes
Table 73. Abbott Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Abbott Revenue Proportion by Product in 2024
Table 75. Abbott Revenue Proportion by Application in 2024
Table 76. Abbott Revenue Proportion by Geographic Area in 2024
Table 77. Abbott Percutaneous Coronary Intervention (PCI) Treatment Instruments SWOT Analysis
Table 78. Abbott Recent Developments
Table 79. Merit Medical Corporation Information
Table 80. Merit Medical Description and Major Businesses
Table 81. Merit Medical Product Features and Attributes
Table 82. Merit Medical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Merit Medical Recent Developments
Table 84. QualiMe Corporation Information
Table 85. QualiMe Description and Major Businesses
Table 86. QualiMe Product Features and Attributes
Table 87. QualiMe Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. QualiMe Recent Developments
Table 89. Cardionovum Corporation Information
Table 90. Cardionovum Description and Major Businesses
Table 91. Cardionovum Product Features and Attributes
Table 92. Cardionovum Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Cardionovum Recent Developments
Table 94. Curatia Medical Corporation Information
Table 95. Curatia Medical Description and Major Businesses
Table 96. Curatia Medical Product Features and Attributes
Table 97. Curatia Medical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Curatia Medical Recent Developments
Table 99. ASAHI INTECC Corporation Information
Table 100. ASAHI INTECC Description and Major Businesses
Table 101. ASAHI INTECC Product Features and Attributes
Table 102. ASAHI INTECC Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. ASAHI INTECC Recent Developments
Table 104. MicroPort Scientific Corporation Corporation Information
Table 105. MicroPort Scientific Corporation Description and Major Businesses
Table 106. MicroPort Scientific Corporation Product Features and Attributes
Table 107. MicroPort Scientific Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. MicroPort Scientific Corporation Recent Developments
Table 109. Lepu Medical Technology Corporation Information
Table 110. Lepu Medical Technology Description and Major Businesses
Table 111. Lepu Medical Technology Product Features and Attributes
Table 112. Lepu Medical Technology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Lepu Medical Technology Recent Developments
Table 114. Shanghai INT Medical Instruments Corporation Information
Table 115. Shanghai INT Medical Instruments Description and Major Businesses
Table 116. Shanghai INT Medical Instruments Product Features and Attributes
Table 117. Shanghai INT Medical Instruments Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Shanghai INT Medical Instruments Recent Developments
Table 119. BrosMed Medical Corporation Information
Table 120. BrosMed Medical Description and Major Businesses
Table 121. BrosMed Medical Product Features and Attributes
Table 122. BrosMed Medical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. BrosMed Medical Recent Developments
Table 124. OrbusNeich Medical Company Corporation Information
Table 125. OrbusNeich Medical Company Description and Major Businesses
Table 126. OrbusNeich Medical Company Product Features and Attributes
Table 127. OrbusNeich Medical Company Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. OrbusNeich Medical Company Recent Developments
Table 129. Shunmei Medical Corporation Information
Table 130. Shunmei Medical Description and Major Businesses
Table 131. Shunmei Medical Product Features and Attributes
Table 132. Shunmei Medical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 133. Shunmei Medical Recent Developments
Table 134. Suzhou Innomed Medical Device Corporation Information
Table 135. Suzhou Innomed Medical Device Description and Major Businesses
Table 136. Suzhou Innomed Medical Device Product Features and Attributes
Table 137. Suzhou Innomed Medical Device Revenue (US$ Million) and Gross Margin (2020-2025)
Table 138. Suzhou Innomed Medical Device Recent Developments
Table 139. APT Medical Corporation Information
Table 140. APT Medical Description and Major Businesses
Table 141. APT Medical Product Features and Attributes
Table 142. APT Medical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. APT Medical Recent Developments
Table 144. Zhejiang Barty Medical Technology Corporation Information
Table 145. Zhejiang Barty Medical Technology Description and Major Businesses
Table 146. Zhejiang Barty Medical Technology Product Features and Attributes
Table 147. Zhejiang Barty Medical Technology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 148. Zhejiang Barty Medical Technology Recent Developments
Table 149. Shenzhen MicroApproach Medical Technology Corporation Information
Table 150. Shenzhen MicroApproach Medical Technology Description and Major Businesses
Table 151. Shenzhen MicroApproach Medical Technology Product Features and Attributes
Table 152. Shenzhen MicroApproach Medical Technology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 153. Shenzhen MicroApproach Medical Technology Recent Developments
Table 154. Beijing Demax Medical Technology Corporation Information
Table 155. Beijing Demax Medical Technology Description and Major Businesses
Table 156. Beijing Demax Medical Technology Product Features and Attributes
Table 157. Beijing Demax Medical Technology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 158. Beijing Demax Medical Technology Recent Developments
Table 159. JW Medical Systems Corporation Information
Table 160. JW Medical Systems Description and Major Businesses
Table 161. JW Medical Systems Product Features and Attributes
Table 162. JW Medical Systems Revenue (US$ Million) and Gross Margin (2020-2025)
Table 163. JW Medical Systems Recent Developments
Table 164. SINOMED Corporation Information
Table 165. SINOMED Description and Major Businesses
Table 166. SINOMED Product Features and Attributes
Table 167. SINOMED Revenue (US$ Million) and Gross Margin (2020-2025)
Table 168. SINOMED Recent Developments
Table 169. Kinhely Bio-Tech Corporation Information
Table 170. Kinhely Bio-Tech Description and Major Businesses
Table 171. Kinhely Bio-Tech Product Features and Attributes
Table 172. Kinhely Bio-Tech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 173. Kinhely Bio-Tech Recent Developments
Table 174. Shandong Huaan Biotechnology Corporation Information
Table 175. Shandong Huaan Biotechnology Description and Major Businesses
Table 176. Shandong Huaan Biotechnology Product Features and Attributes
Table 177. Shandong Huaan Biotechnology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 178. Shandong Huaan Biotechnology Recent Developments
Table 179. Blue Sail Medical Corporation Information
Table 180. Blue Sail Medical Description and Major Businesses
Table 181. Blue Sail Medical Product Features and Attributes
Table 182. Blue Sail Medical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 183. Blue Sail Medical Recent Developments
Table 184. Shanghai Bio-heart Biological Technology Corporation Information
Table 185. Shanghai Bio-heart Biological Technology Description and Major Businesses
Table 186. Shanghai Bio-heart Biological Technology Product Features and Attributes
Table 187. Shanghai Bio-heart Biological Technology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 188. Shanghai Bio-heart Biological Technology Recent Developments
Table 189. Raw Materials Key Suppliers
Table 190. Distributors List
Table 191. Market Trends and Market Evolution
Table 192. Market Drivers and Opportunities
Table 193. Market Challenges, Risks, and Restraints
Table 194. Research Programs/Design for This Report
Table 195. Key Data Information from Secondary Sources
Table 196. Key Data Information from Primary Sources
List of Figures
Figure 1. Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Picture
Figure 2. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Interventional Treatment Instruments Product Picture
Figure 4. Coronary Pathway Assistive Instruments Product Picture
Figure 5. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Others
Figure 9. Percutaneous Coronary Intervention (PCI) Treatment Instruments Report Years Considered
Figure 10. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (2020-2031) & (US$ Million)
Figure 12. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Market Share by Region (2020-2031)
Figure 14. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Market Share Ranking (2024)
Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 16. Interventional Treatment Instruments Revenue Market Share by Player in 2024
Figure 17. Coronary Pathway Assistive Instruments Revenue Market Share by Player in 2024
Figure 18. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Market Share by Type (2020-2031)
Figure 19. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Market Share by Application (2020-2031)
Figure 20. North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue YoY (2020-2031) & (US$ Million)
Figure 21. North America Top 5 Players Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (US$ Million) in 2024
Figure 22. North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (US$ Million) by Type (2020 - 2031)
Figure 23. North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (US$ Million) by Application (2020-2031)
Figure 24. US Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (2020-2031) & (US$ Million)
Figure 25. Canada Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (2020-2031) & (US$ Million)
Figure 26. Mexico Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (2020-2031) & (US$ Million)
Figure 27. Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue YoY (2020-2031) & (US$ Million)
Figure 28. Europe Top 5 Players Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (US$ Million) in 2024
Figure 29. Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (US$ Million) by Type (2020-2031)
Figure 30. Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (US$ Million) by Application (2020-2031)
Figure 31. Germany Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (2020-2031) & (US$ Million)
Figure 32. France Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (2020-2031) & (US$ Million)
Figure 33. U.K. Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (2020-2031) & (US$ Million)
Figure 34. Italy Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (2020-2031) & (US$ Million)
Figure 35. Russia Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue YoY (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Top 8 Players Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (US$ Million) in 2024
Figure 38. Asia-Pacific Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (US$ Million) by Type (2020-2031)
Figure 39. Asia-Pacific Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (US$ Million) by Application (2020-2031)
Figure 40. Indonesia Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (2020-2031) & (US$ Million)
Figure 41. Japan Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (2020-2031) & (US$ Million)
Figure 42. South Korea Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (2020-2031) & (US$ Million)
Figure 43. Australia Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (2020-2031) & (US$ Million)
Figure 44. India Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (2020-2031) & (US$ Million)
Figure 45. Indonesia Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (2020-2031) & (US$ Million)
Figure 46. Vietnam Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (2020-2031) & (US$ Million)
Figure 47. Malaysia Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (2020-2031) & (US$ Million)
Figure 48. Philippines Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (2020-2031) & (US$ Million)
Figure 49. Singapore Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (2020-2031) & (US$ Million)
Figure 50. Central and South America Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Central and South America Top 5 Players Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (US$ Million) in 2024
Figure 52. Central and South America Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (US$ Million) by Type (2020-2031)
Figure 53. Central and South America Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (US$ Million) by Application (2020-2031)
Figure 54. Brazil Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (2020-2025) & (US$ Million)
Figure 55. Argentina Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (2020-2025) & (US$ Million)
Figure 56. Middle East and Africa Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue YoY (2020-2031) & (US$ Million)
Figure 57. Middle East and Africa Top 5 Players Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (US$ Million) in 2024
Figure 58. South America Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (US$ Million) by Type (2020-2031)
Figure 59. Middle East and Africa Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (US$ Million) by Application (2020-2031)
Figure 60. GCC Countries Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (2020-2025) & (US$ Million)
Figure 61. Israel Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (2020-2025) & (US$ Million)
Figure 62. Egypt Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (2020-2025) & (US$ Million)
Figure 63. South Africa Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (2020-2025) & (US$ Million)
Figure 64. Percutaneous Coronary Intervention (PCI) Treatment Instruments Industry Chain Mapping
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
